Parathyroid hormone-related protein secretion is inhibited by oestradiol and stimulated by antioestrogens in KPL-3C human breast cancer cells

British Journal of Cancer

Volumn 75, Issue 12, 1997, Pages 1819-1825

  Kurebayashi, J ^a   Sonoo, H ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Antioestrogen; Breast cancer; Cell cycle; Oestrogen receptor; Parathyroid hormone related protein

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; PARATHYROID HORMONE; TAMOXIFEN;

ARTICLE; CELL CYCLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; PROTEIN SECRETION; TUMOR CELL LINE;

EID: 0031006028     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.310     Document Type: Article

References (42)

1. Akino K, Ohtsuru A, Yano H, Ozeki S, Namba H, Nakashima M, Ito M, Matsumoto T and Yamashita S (1996) Antisense inhibition of parathyroid hormone-related peptide gene expression reduces malignant pituitary tumor progression and metastases in rat. Cancer Res 56: 77-86
2. Allinson ET and Drucker DJ (1992) Parathyroid hormone-like peptide shares features with members of the early response gene family: rapid induction by serum, growth factors, and cycloheximide. Cancer Res 52: 3103-3109
3. Benitez-Verguizas and Esbrit P (1994) Proliferative effect of parathyroid hormone-related protein on the hypercalcemic Walker 256 carcinoma cell line. Biochem Biophys Res Commun 198: 1281-1289
4. Birch MA, Carron JA, Scott M, Fraser WD and Gallagher JA (1995) Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor expression and mitogenic responses in human breast cancer cell lines. Br J Cancer 72: 90-45
5. Bundred NJ, Ratcliffe WA, Walker RA, Coley S, Morrison JM and Ratcliffe JG (1991) Parathyroid hormone-related protein and hypercalcemia in breast cancer. Br Med J 303: 1506-1509
6. Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP, Olson BR, Wu TL, Mitnick ME, Broadus AE and Stewart AF (1990) Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl Med 322: 1106-1112
7. Coleman RE, Whitaker KB, Moss DW, Mashiter G, Fogelman I and Rubens RD (1988) Biochemical prediction of response of bone metastases to treatment. Br J Cancer 58: 205-210
8. Deftos LJ, Houge-Angeletti R, Chalberg C and Tu S (1989) PTHrP secretion is stimulated by CT and inhibited by CgA peptides. Endocrinology 125: 563-565
9. Dvir R, Golander A, Jaccard N, Yedwab G, Otremski I, Spirer Z and Weisman (1995) Amniotic fluid and plasma levels of parathyroid hormone-related protein and hormonal modulation of its secretion by amniotic fluid cells. Eur J Endocrinol 133: 277-282
10. Emly JF, Hughes S, Green E and Ratcliffe WA (1994) Expression and secretion of parathyroid hormone-related protein by a human cancer cell line. Biochim Biophys Acta 1220: 193-198
11. Endo K, Ichikawa F, Uchiyama Y, Katsumata K, Ohkawa H, Kumaki K, Ogata E and Ikeda K (1994) Evidence for the uptake of a vitamin D analogue (OCT) by a human carcinoma and its effect of suppressing the transcription of parathyroid hormone-related peptide gene in vivo. J Biol Chem 269: 32693-32699
12. Ferrari SL, Rizzoli R and Bonjour JP (1992) Parathyroid hormone-related protein production by primary cultures of mammary epithelial cells. J Cell Physiol 150: 304-311
13. Grill V, Ho P, Moseley JM, Johnason N, Lee S, Body JJ, Kukreja S and Martin TJ (1991) Parathyroid hormone-related protein: elevated levels both in humoral hypercalcemia of malignancy and in hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 73: 1309-1315
14. Henderson J, Sebag M, Rhim J, Goltzman D and Kremer R (1991) Dysregulation of parathyroid hormone-like peptide expression and secretion in a keratinocyte model of tumor progression. Cancer Res 51: 6521-6528
15. Holt EH, Lu C, Dreyer BE, Dannies PS and Broadus AE (1994) Regulation of parathyroid hormone-related peptide gene expression by estrogen in GH4C1 rat pituitary cells has the pattern of a primary response gene. J Neurochem 62: 1239-1246
16. Ikeda K, Ohno H, Hane M, Yokoi H, Okada M, Honma T, Yamada A, Tatsumi Y, Tanaka T, Saitoh T, Hirose S, Mori S, Takeuchi Y, Fukumoto S, Terukina S, Iguchi H, Kiriyama T, Ogata E and Matsumoto T (1994) Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma. J Clin Endocrinol Metab 79: 1322-1327
17. Inoue D, Matsumoto T, Ogata E and Ikeda K (1993) 22-oxacalcitriol, noncalcemic analogue of calcitriol, suppresses both cell proliferation and parathyroid hormone-related peptide gene expression in human T cell lymphotrophic virus, type 1-infected T cells. J Biol Chem 268: 16730-16736
18. Iwamura M, Wu G, Abrahamsson PA, Cockett ATK, Foss KA and Deftos LJ (1994) Parathyroid hormone-related protein: a potential autocrine growth regulator in human prostate cancer cell lines. Urology 43: 675-679
19. Kaiser SM, Lanevrille P, Bernier SM, Rhim JS, Kremer R and Goltzman D (1992) Enhanced growth of a human keratinocyte cell line induced by antisense RNA for parathyroid hormone-related protein. J Biol Chem 267: 13623-13628
20. Kasahara H, Tsuchiya M, Adachi R, Hirokawa S, Tanaka S and Tachibana S (1992) Development of a C-terminal-region-specific radioimmunoassay of parathyroid hormone-related protein. Biomed Res 13: 155-161
21. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R and Dickson RB (1987) Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417-428
22. Kremer R, Karaplis AC, Henderson J, Gulliver W, Banville D, Hendy GN and Goltzman D (1991) Regulation of parathyroid hormone-like peptide in cultured normal human keratinocyles. J Clin Invest 87: 884-893
23. Kurebayashi J, Kurosumi M and Sonoo H (1996) A new human breast cancer cell line, KPL-3C secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice. Br J Cancer 74: 200-207
24. Li X and Drucker DJ (1994) Parathyroid hormone-related protein is a downstream target for ras and src activation. J Biol Chem 269: 6263-6266
25. Luparello C, Burtis WJ, Raue F, Birch MA and Gallagher JA (1995) Parathyroid hormone-related peptide and 8701-BC breast cell growth and invasion in vitro: evidence for growth-inhibiting and invasion-promoting effects. Mol Cell Endocrinol 111: 225-232
26. Martin TJ, Moseley JM and Gillespie MT (1991) Parathyroid hormone-related protein: biochemistry and molecular biology. Crit Rev Biochem Mol Biol 26: 377-395
27. Merryman JJ, DeWille JW, Werkmeister JR, Capen CC and Rosol TJ (1994) Effects of transforming growth factor-β on parathyroid hormone-related protein production and ribonucleic acid expression by a squamous carcinoma cell line in vitro. Endocrinology 134: 2424-2430
28. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall REH, Kemp BE, Suva LJ, Rodda CP, Ebeling PR, Hudson PJ, Zajac JD and Martin TJ (1987) Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 84: 5048-5052
29. Paspaliaris V, Vargas SJ, Gillespie MT, Williams ED, Danks JA, Moseley JM, Story ME, Pennefather JN, Leaver DD and Martin TJ (1992) Oestrogen enhancement of the myometrial response to exogenous parathyroid hormone-related protein (PTHrP) and tissue localization of endogenous PTHrP and its mRNA in the virgin rat uterus. J Endocrinol 134: 415-425
30. Plotkin D, Lechner JJ, Jung WE and Rosen PJ (1978) Tamoxifen flare in advanced breast cancer. JAMA 240: 2644-2646
31. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennett RC and Martin TJ (1991) Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51: 3059-3061
32. Ratcliffe WA, Hutchesson ACJ, Hundred NJ and Ratcliffe JG (1992) Role of assays for parathyroid-hormone-related protein in investigation of hypercalcemia. Lancet 339: 164-167
33. Rizzoli R, Aubert ML, Sappino AP and Bonjour JP (1994) Cyclic AMP increases the release of parathyroid hormone-related protein from a lung-cancer cell line. Int J Cancer 56: 422-426
34. Scholl SM, Huff KK and Lippman ME (1983) Antiestrogenic effects of LY117018 in MCF-7 cells. Endocrinolgy 113: 611-617
35. Sebag M, Henderson J, Goltzman D and Kremer R (1994) Regulation of parathyroid hormone-related peptide production in normal human mammary epithelial cells in vitro. Am J Physiol 267: C723-C730
36. Southby J, Kissin MW, Danks JA, Hayman JA, Moseley JM, Henderson MA, Bennett RC and Martin TJ (1990) Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res 50: 7710-7716
37. Sutherland RL, Reddel RR, Murphy LC and Taylor IW (1986) Effects of antiestrogens on cell cycle progression. In Estrogen/Antiestrogen Action and Breast Cancer Therapy, Jordan VC. (ed.), pp. 265-279. The University of Wisconsin Press: Wisconsin
38. Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY, Hudson PJ, Martin TJ and Wood WI (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237: 893-896
39. Tabuenca A, Mohan S, Garberoglio CA, Borgen PI, Rosol T and Linkhart TA (1995) Parathyroid hormone-related protein: primary osteolytic factor produced by breast tumor cells in vitro? World J Surg 19: 292-297
40. Thiede MA (1989) The mRNA encoding a parathyroid hormone-related peptide is produced in mammary tissue in response to deviations in serum prolactin. Mol Endocrinol 3: 1443-1447
41. Thiede MA, Harm SC, Hasson DM and Gardner RM (1991) In vivo regulation of parathyroid hormone-related peptide messenger ribonucleic acid in the rat uterus by 17β-estradiol. Endocrinology 128: 2317-2323
42. Vargas SJ, Gillespie MT, Powell GJ, Southby J, Danks JA, Moseley JM and Martin TJ (1992) Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J Bone Miner Res 7: 971-979